are presented. They had had "classic" RA (American Rheumatism Association criteria) for 2, 19 and 23 years respectively before they developed neurological symptoms. Lower limb weakness was the presenting complaint in all patients, followed by footdrop, distal upper and lower limb wasting and bulbar symptoms in two. Tongue fibrillation was evident in these two patients whereas all had a brisk jaw jerk and a combination of upper and lower motor neurone signs in the limbs with intact sensation.
Serum creatine kinase was moderately elevated in one. There were electromyographic signs of widespread chronic partial denervation with abundant spontaneous activity in the presence of normal motor conduction velocities and sensory action potentials. The CSF contents were normal. Quadriceps muscle biopsies revealed angular fibres and small fibre type grouping characteristic of partial denervation. Relentless progression of the disease resulted in the death of two patients after 20 and 34 months respectively, the surviving patient being wheelchairbound 23 months after presentation.
This association raises important issues regarding the aetiology of so-called motor neuropathies in collagen disorders and the possibility of immunological mechanisms in some forms of MND. All patients in Thessaloniki had abnormal PR VEP latencies when the abnormal eye was stimulated. The 'b' wave of the ERG of the abnormal eye (x = 64 1uV + 1-8) was consistently smaller (x = 105 pV ± 2-3) in amplitude compared with the normal eye (p < 0-001) or 10 normal control subjects' eyes (x = 112pV + 2-9) (p < 0-001 There are three antigenically distinct subProceedings of the Association of British Neurologists types of interferon (IFN). Studies using bioassays have suggested that IFN-a and IFN-,B are produced in response to viral infection, whereas IFN-y production is induced by immunological mechanisms. IFN-y will induce the expression of class II MHC antigens in tissues which do not normally express them. It has been suggested that this mechanism may trigger autoimmunity.
Using highly sensitive and specic immunoradiometric assays (IRMA) we have measured IFN-a and IFN-y in CSF of patients with infectious and immunologically mediated neurological disorders. Both immunoreactive IFN-a and IFN-y were present in the CSF in the acute phase of viral meningitis, but no IFN was found in other neurological disorders such as multiple sclerosis and Guillan-Barre Syndrome.
IRMAs have not been previously applied to the study of IFN in CSF, and INF-y has not previously been detected in CSF. Its presence in CSF following viral infection gives support to the hypothesis that a preceding viral infection may trigger autoimmune disorders which involve the nervous system. Clinical examination provides information on muscle groups, for example, posterior lower limb muscles, but does not permit differentiation of the relative contribution to muscle strength from individual muscles.
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The development of modem generations of CT scanners has permitted more detailed assessment of the extent of the disease process.
CT scanning has been applied to 75 patients with histologically verified SMA of varied presentation and disease duration. CT evaluation was carried out without knowledge of the clinical features or disease duration.
This study has shown there appears to be a recognisable CT appearance in SMA. This was seen irrespective of the clinical mode of presentation. Abnormalities have been demonstrated in mildly affected individuals within families whose older members have shown marked clinical and CT abnormalities, suggesting that the degree of CT abnormalities depends on the disease duration.
Further studies of CT and SMA may obviate the need for muscle biopsy of more than one family member. The investigations were-repeated thrice before and 20'-45' after each TRH-T administration (2 and 4 mg/im) and after placebo.
Significant improvement was observed in comparison with placebo (P) 45' after 2 mg/TRH (II) and particularly after 4mg/TRH (IV) in the patient CR whose spasticity was the most severe. Vmx: P + 8%; II +25%; IV +45%. First Wartenberg oscillation: P + 15%; II + 20%; IV +27%. Phasic stretch reflex: P -25%; II -55%; IV -50%. Improvement in gait veolocity: P + 20%; II +36%; IV +42%. Some improvement (IV) was still evident 24 h later. Shoulder abduction fatigue has been assessed in normal subjects and patients with peripheral neuromuscular diseases. Maximum voluntary isometric strength was measured in the non-dominant shoulder abductors, with the subject seated, in ten brief successive contractions over a period of 50-55 seconds using a hand held myometer. A fatigue index (FI) was calculated as the difference between the means of the first and last two contractions expressed as a percentage of the first two. Maximum force was not critically dependent on shoulder angle.
In twenty-five normal males (aged 20-60, median 34 years) force declined from the first to the fifth contraction and then remained constant: Fl was 6-1 +/-6-7% (mean + /-sd). In twenty-five normal females (aged 20-65, median 30 years) force increased from the first to the second contraction and then declined: FI was 6 1 + /-6-4%, no different to males. Fl was independent ofinitial strength and age in this limited sample.
Most patients with myasthenic disorders, on treatment, showed excess fatigue unrelated to weakness as did many with mitochondrial myopathy. Excess fatigue rarely occurred in other disorders. The Gabapentin is a gaba analogue with antiepileptic properties in animals. A double blind, cross-over, add-on trial with 3
